Norlase secured €20M in venture debt from the European Investment Bank to fuel accelerated growth worldwide.
Norlase is a global ophthalmic company developing advanced laser solutions for retina and glaucoma treatment
Norlase is a global ophthalmic company developing advanced laser solutions for retina and glaucoma treatment. It focuses on next-generation laser technologies and has received EU MDR certification ahead of the deadline.